Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Plx Pharma Inc (PLXP)

Plx Pharma Inc (PLXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,669
  • Shares Outstanding, K 9,044
  • Annual Sales, $ 750 K
  • Annual Income, $ 900 K
  • 60-Month Beta 5.18
  • Price/Sales 64.26
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.50
  • Number of Estimates 2
  • High Estimate -0.49
  • Low Estimate -0.50
  • Prior Year -0.39
  • Growth Rate Est. (year over year) -28.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.00 +3.20%
on 09/09/19
6.53 -21.03%
on 08/14/19
-0.17 (-3.19%)
since 08/13/19
3-Month
4.86 +6.17%
on 06/17/19
7.41 -30.36%
on 07/01/19
+0.21 (+4.24%)
since 06/13/19
52-Week
1.00 +416.00%
on 12/27/18
7.41 -30.36%
on 07/01/19
+0.76 (+17.27%)
since 09/13/18

Most Recent Stories

More News
PLx Pharma Inc. Presents Moderated Abstract and Simultaneous Publication on the Pharmacokinetic and Pharmacodynamics (PK/PD) Properties of its Novel, Liquid Aspirin Formulation at the 2019 European Society of Cardiology Congress

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on developing more effective and safer products with its patent-protected PLxGuard(TM) delivery...

PLXP : 5.16 (-3.55%)
PLx Pharma Inc. to Present at Janney Healthcare Conference 2019 on September 10

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard(TM) delivery...

PLXP : 5.16 (-3.55%)
PLx Pharma Inc. Reports Second Quarter 2019 Results

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard(TM) delivery...

PLXP : 5.16 (-3.55%)
Earnings Preview: PLx Pharma (PLXP) Q2 Earnings Expected to Decline

PLx Pharma (PLXP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PLXP : 5.16 (-3.55%)
PLx Pharma Inc. to Discuss 2019 Second Quarter Financial Results on August 9, 2019 Conference Call

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard(TM) delivery...

PLXP : 5.16 (-3.55%)
PLx Pharma Inc. Reports First Quarter 2019 Results

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard(TM) delivery...

PLXP : 5.16 (-3.55%)
PLx Pharma (PLXP) Expected to Beat Earnings Estimates: Should You Buy?

PLx Pharma (PLXP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PLXP : 5.16 (-3.55%)
PLx Pharma Inc. to Discuss 2019 First Quarter Financial Results on May 10, 2019 Conference Call

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard(TM) delivery...

PLXP : 5.16 (-3.55%)
PLx Pharma Inc. to Discuss 2018 Fourth Quarter and Full Year Financial Results on March 8, 2019 Conference Call

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore(TM) 325 mg and Vazalore(TM) 81...

PLXP : 5.16 (-3.55%)
PLx Pharma Inc. Announces Adjournment of Special Meeting of Stockholders

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore(TM) 325 mg and Vazalore(TM) 81...

PLXP : 5.16 (-3.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade PLXP with:

Business Summary

PLx Pharma Inc. is a specialty pharmaceutical company. It focused on developing clinically validated and patent-protected PLxGuard(TM) delivery system to provide safe and effective aspirin products. PLx Pharma Inc., formerly known as Dipexium Pharmaceuticals Inc., is based in NEW YORK, United States....

See More

Key Turning Points

2nd Resistance Point 5.53
1st Resistance Point 5.35
Last Price 5.16
1st Support Level 5.07
2nd Support Level 4.97

See More

52-Week High 7.41
Last Price 5.16
Fibonacci 61.8% 4.96
Fibonacci 50% 4.20
Fibonacci 38.2% 3.45
52-Week Low 1.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar